390 related articles for article (PubMed ID: 29514412)
1. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia and proton-pump inhibitors.
Famularo G; Gasbarrone L; Minisola G
Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
[TBL] [Abstract][Full Text] [Related]
4. [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].
Piezzi V; Kullak-Ublick GA; Glisenti P
Internist (Berl); 2014 Feb; 55(2):199-205. PubMed ID: 24419536
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of Hypomagnesemia in Hospitalized Type 2 Diabetic Patients Treated with Diuretics and/or Proton Pump Inhibitors.
Mengesha B; Levi D; Kroonenberg M; Koren R; Golik A; Koren S
Isr Med Assoc J; 2021 Apr; 23(4):245-250. PubMed ID: 33899358
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
8. [Drugs affecting serum magnesium concentration].
Kawamura Y
Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
[TBL] [Abstract][Full Text] [Related]
9. Recent safety concerns with proton pump inhibitors.
Chen J; Yuan YC; Leontiadis GI; Howden CW
J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
[TBL] [Abstract][Full Text] [Related]
10. Proton-pump inhibitor use is associated with low serum magnesium concentrations.
Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ
Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090
[TBL] [Abstract][Full Text] [Related]
11. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Effect of High-Dose Pantoprazol on Serum and Urinary Magnesium Levels.
Uyar S; Dolu S; Yolcular BO; Ellidag HY; Kok M; Bostan F; Sahinturk Y; Cekin AH
Clin Lab; 2018 Mar; 64(3):263-268. PubMed ID: 29739099
[TBL] [Abstract][Full Text] [Related]
13. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.
Koulouridis I; Alfayez M; Tighiouart H; Madias NE; Kent DM; Paulus JK; Jaber BL
Am J Kidney Dis; 2013 Oct; 62(4):730-7. PubMed ID: 23664547
[TBL] [Abstract][Full Text] [Related]
14. Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.
Cheminet G; Clain G; Jannot AS; Ranque B; Passeron A; Michon A; De Luna G; Diehl JL; Oudard S; Cellier C; Karras A; Vedié B; Prot-Bertoye C; Pouchot J; Arlet JB
Intern Emerg Med; 2018 Dec; 13(8):1201-1209. PubMed ID: 29951810
[TBL] [Abstract][Full Text] [Related]
15. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
16. [Review: UPDATE on magnesium metabolism].
Fatuzzo P; Zanoli L; Scollo V; Portale G; Gaudio A; Pani A; Granata A
G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134397
[TBL] [Abstract][Full Text] [Related]
17. Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
Abu-Amna M; Bar-Sela G
Cancer Chemother Pharmacol; 2019 Mar; 83(3):545-550. PubMed ID: 30547192
[TBL] [Abstract][Full Text] [Related]
18. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
Hughes J; Y Y Chiu D; Kalra PA; Green D
PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
[TBL] [Abstract][Full Text] [Related]
20. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
